Discovery of a Type III Inhibitor of LIM Kinase 2
That Binds in a DFG-Out Conformation
- Publication date
- Publisher
Abstract
The first allosteric, type III inhibitor
of LIM-kinase 2 (LIMK2)
is reported. A series of molecules that feature both an <i>N</i>-phenylsulfonamide and tertiary amide were not only very potent at
LIMK2 but also were extremely selective against a panel of other kinases.
Enzymatic kinetic studies showed these molecules to be noncompetitive
with ATP, suggesting allosteric inhibition. X-ray crystallography
confirmed that these sulfonamides are a rare example of a type III
kinase inhibitor that binds away from the highly conserved hinge region
and instead resides in the hydrophobic pocket formed in the DFG-out
conformation of the kinase, thus accounting for the high level of
selectivity observed